From screening to post-treatment monitoring, Clinical Genomics is by your side every step of the way – serving as your expert partner in safeguarding your health.
GET SCREENED.
DETECT EARLY. PRESERVE LIFE. |
TAKE CONTROL.
MONITOR. REGULARLY. |
InSure® ONE™: An easy home-collection test for detection of blood in stool.
|
COLVERA®: Blood test that monitors for recurrence by detecting circulating tumor DNA.
|
The Clinical Genomics Difference
Clinical Genomics has two decades of experience striving to save lives and reduce costs by developing easy-to-use tests for use in the detection of colorectal cancer. With breakthrough diagnostic tools, the company offers affordable and accurate tests, supporting physicians and patients with potential life-saving knowledge about colorectal cancer.
Recent News & Events
Clinical Genomics Announces New Publication from Flinders Medical Centre, Highlighting the Use of COLVERA® as a Quantitative ctDNA Biomarker for Response to Colorectal Cancer Therapy
February 18, 2022
|
Clinical Genomics Announces Expansion of Medicare Coverage of COLVERA Liquid Biopsy for Colorectal Cancer Molecular Residual Disease and Recurrence Detection
October 5, 2021
|